The major strength of the study is that sex hormone levels in both cases and controls were measured simultaneously by a validated and highly sensitive assay, providing unique data of sex hormone levels in women with hypopituitarism and a population-based control group. The gene discussed is PLXNA3; the disease is hypopituitarism.